However, in MDD in vitro experiments, sub-anesthetic doses of ketamine, an antidepressant (Murrough et al., 2013), program human monocytes into M2c-like macrophages (anti-inflammatory phenotype) by inducing high levels of CD163 and MERTK (Nowak et al., 2019). Here, CD163 is linked to major depressive disorder.